New CEO reinforces cryoWrite team

CryoWrite AG is pleased to announce the appointment of Christoph Bally as its new Chief Executive Officer, effective immediately. Christoph brings a strong leadership track record in deep-tech and life-science industries, with extensive experience guiding innovative technologies from early development to successful commercialisation. His background spans strategic management, product development, and the scaling of high-growth technology organisations.

As CryoWrite enters its next phase of expansion, Christoph will lead the company in strengthening its market position and accelerating the deployment of its flagship product, the cryoWriter, the next-generation automated platform for cryo-EM sample preparation.

His appointment supports CryoWrite’s mission to deliver robust, user-centric solutions that address the growing needs of the global cryo-electron microscopy community. He will also support us in adapting the team structure and processes as we are growing at a rapid pace.

“Christoph joins CryoWrite at an crucial moment,” said the Board of Directors. “His strategic vision, industry insight, and leadership experience make him exceptionally well-suited to guide the company through its upcoming milestones, including market launch, customer expansion, and continued innovation.”

Christoph Bally added: “CryoWrite’s technology has the potential to transform an essential step in cryo-EM workflows. I am excited to work with this talented team and to support researchers and facilities with solutions that increase accessibility, reproducibility, and throughput in structural biology.”

CryoWrite AG continues to build momentum as it prepares for commercialisation and broader international engagement. The company looks forward to advancing its mission under Christoph’s leadership.